GlaxoSmithKline said to eye sale of $3.9b stake in India's HUL

FILE PHOTO: The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera

Swaraj Singh Dhanjal

30 April, 2020

GlaxoSmithKline Plc.Hindustan Unilever Ltd

Printed by Unregistered user on Sat, 20 Dec 2025 02:35:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

GlaxoSmithKline said to eye sale of $3.9b stake in India's HUL

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

India: HUL buys Horlicks as company completes merger with GSK Consumer

India Digest: Embibe buys Funtoot; GSK looks to exit HUL; EaseMyTrip IPO

Read more from India

Japan’s MUFG to buy 20% stake in India’s Shriram Finance for $4.4b

PUBG maker Krafton leads S Korean trio in $666m India tech bet

GlaxoSmithKline said to eye sale of $3.9b stake in India's HUL

Register Now to Unlock Premium Content

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

India: HUL buys Horlicks as company completes merger with GSK Consumer

India Digest: Embibe buys Funtoot; GSK looks to exit HUL; EaseMyTrip IPO

Read more from India

Japan’s MUFG to buy 20% stake in India’s Shriram Finance for $4.4b

PUBG maker Krafton leads S Korean trio in $666m India tech bet